The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Effect of 12-month dehydroepiandrosterone replacement therapy on bone, vagina and endometrium in postmenopausal women.
Abstract
The effect of 12-month dehydroepiandrosterone (DHEA) replacement therapy has been evaluated in 14 60- to 70-yr-old women who received daily applications of a 10% DHEA cream. Vaginal epithelium maturation was stimulated by DHEA administration in 8 of 10 women who had a maturation value of zero at the onset of therapy, whereas a stimulatory effect was also seen in all three women who had an intermediate vaginal maturation index before therapy. The estrogenic effect of DHEA observed in the vagina was not observed in the endometrium, which remained atrophic in all women. Most interesting, the bone mineral density significantly increased at the hip from 0.744 +/- 0.021 to 0.759 +/- 0.025 g/cm2 after 12 months of treatment (P < 0.05). These changes in bone mineral density were associated with a significant 20.0% decrease (P < 0.01) in plasma bone alkaline phosphatase and a 28% decrease in the urinary hydroxyproline/creatinine ratio. A 2.1-fold increase over the control value (P < 0.01) in plasma osteocalcin was concomitantly observed. The present data describe for the first time a series of medically important beneficial effects of DHEA therapy in postmenopausal women through transformation of the precursor steroid DHEA into androgens and/or estrogens in specific peripheral intracrine tissues without significant adverse effects. The stimulatory effect on the vaginal epithelium in the absence of stimulation of the endometrium is of particular interest because it eliminates the need for progestin replacement therapy. On the other hand, the stimulatory effect on bone mineral density accompanied by an increase in serum osteocalcin, a marker of bone formation, suggests stimulation of bone formation by the androgenic action of DHEA, a finding of particular interest for both the prevention and treatment of osteoporosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“second, other studies of DHEA therapy in postmenopausal women (9) or aging (40,47) have also shown selective improvement in BMD at this site.”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [9]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“positive effects of DHEA replacement have been described on psychological well-being (6), body composition (7,8), and bone mineral density (BMD) (9) in older, normal adults.”
From Long-Term DHEA Replacement in Primary Adrenal Insufficiency: A Randomized, Controlled Trial (2008) · cites this paper as [9]
In the citing paper
“the absence of a stimulatory effect of DHEA on the human endometrium (73, 280) eliminates the need to administer a progestin to neutralize the stimulatory effect of estrogens in this tissue.”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [280]
In the citing paper
“Bone mass density was increased by 2.3% at the hip, 3.75% at the hip Ward's triangle, and 2.2% at the lumbar spine level (all P Ͻ 0.05; Ref. 280).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [280]
In the citing paper
“women, at menopause, are not only deprived from estrogens because of a rapid loss of ovarian activity but also have been deprived from androgens for a longer period because of a progressive decrease of serum DHEA levels starting quite a few years before menopause.”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [280]
In the citing paper
“the estrogenic stimulatory effect observed in the vagina was not found in the endometrium, which remained completely atrophic in all women after 12 months of DHEA treatment (280).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [280]
In the citing paper
“We have also determined that the serum levels of DHEA using a 10% cream (280) were comparable to the ones obtained after daily oral administration of 100 mg of DHEA (our unpublished data).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [280]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women.
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C., Rosner, B., & Speizer, F. E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506153322401 · Cited by 1,487
ORENTREICH, N., BRIND, J. L., RIZER, R. L., & VOGELMAN, J. H. (1984) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-59-3-551 · Cited by 1,349
Effects of replacement dose of dehydroepiandrosterone in men and women of advancing age.
Morales, A. J., Nolan, J. J., Nelson, J. C., & Yen, S. S. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.6.7515387 · Cited by 841
Determination of serum creatinine by a direct colorimetric method
Heinegård, D. K., & Tiderström, G. (1973) · Clinica Chimica Acta · doi:10.1016/0009-8981(73)90466-x · Cited by 724
Labrie, F., Bélanger, A., Cusan, L., Gomez, J.-L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4160 · Cited by 713
Self-citationA prospective study of dehydroepiandrosterone sulfate, mortality and cardiovascular disease.
Barrett-Connor, E., Khaw, K.-T., & Yen, S. S. C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612113152405 · Cited by 681
The Functions of Corticosteroid-Binding Globulin and Sex Hormone-Binding Globulin: Recent Advances*
Rosner, W. (1990) · Endocrine Reviews · doi:10.1210/edrv-11-1-80 · Cited by 560
The effects of testosterone treatment on body composition and metabolism in middle-aged obese men.
Mårin, P., Holmäng, S., Jönsson, L., Sjöström, L., Kvist, H., Holm, G., Lindstedt, G., & Björntorp, P. A. (1992) · PubMed · Cited by 553
Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality
Davis, S. R., McCloud, P., Strauss, B. J., & Burger, H. (1995) · Maturitas · doi:10.1016/0378-5122(94)00898-h · Cited by 534
The key role of 17β-hydroxysteroid dehydrogenases in sex steroid biology
Labrie, F., Luu-The, V., Lin, S.-X., Claude, L., Simard, J., Breton, R., & Bélanger, A. (1997) · Steroids · doi:10.1016/s0039-128x(96)00174-2 · Cited by 480
Self-citationChanges in serum concentrations of conjugated and unconjugated steroids in 40- to 80-year-old men
Bèlanger, A., Candas, B., Dupont, A., Cusan, L., Diamond, P., Gomez, J.-L., & Labrie, F. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.4.7962278 · Cited by 437
Self-citationNESTLER, J. E., BARLASCINI, C. O., CLORE, J. N., & BLACKARD, W. G. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-57 · Cited by 414
The epidemiology of endometrial cancer
Parazzini, F., Vecchia, C. L., Bocciolone, L., & Franceschi, S. (1991) · Gynecologic Oncology · doi:10.1016/0090-8258(91)90246-2 · Cited by 399
The role of androgen in the maintenance of sexual functioning in oophorectomized women.
Sherwin, B. B., & Gelfand, M. M. (1987) · Psychosomatic Medicine · doi:10.1097/00006842-198707000-00009 · Cited by 394
Labrie, F., Bélanger, A., Cusan, L., & Candas, B. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.8.4161 · Cited by 350
Self-citationTherapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice.
Coleman, D. L., Leiter, E. H., & Schwizer, R. W. (1982) · Diabetes · doi:10.2337/diab.31.9.830 · Cited by 317
Comparison of pharmacodynamic properties of various estrogen formulations
Mashchak, C. A., Lobo, R. A., Dozono-Takano, R., Eggena, P., Nakamura, R. M., Brenner, P. F., & Mishell, D. R. (1982) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(82)90218-6 · Cited by 316
Complete androgen blockade for the treatment of prostate cancer.
Labrie, F., Dupont, A., & Bèlanger, A. (1985) · PubMed · Cited by 285
Self-citationDHEA and peripheral androgen and estrogen formation: intracrinology
LABRIE, F., BÉLANGER, A., SIMARD, J., LUU‐THE, V., & LABRIE, C. (1995) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1995.tb17369.x · Cited by 280
Self-citationDehydroepiandrosterone enhances IL2 production and cytotoxic effector function of human T cells.
Suzuki, T., Suzuki, N., Daynes, R. A., & Engleman, E. G. (1991) · Clinical Immunology and Immunopathology · doi:10.1016/s0090-1229(05)80024-8 · Cited by 277
Sherwin, B. B., & Gelfand, M. M. (1985) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(85)90001-8 · Cited by 261
MIGEON, C. J., KELLER, A. R., LAWRENCE, B., & SHEPARD, T. H. (1957) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-17-9-1051 · Cited by 260
Affective changes with estrogen and androgen replacement theraphy in surgically menopausal women
Sherwin, B. B. (1988) · Journal of Affective Disorders · doi:10.1016/0165-0327(88)90061-4 · Cited by 258
Effect of testosterone on abdominal adipose tissue in men.
Rebuffé-Scrive, M., Mårin, P., & Björntorp, P. A. (1991) · PubMed · Cited by 223
Oral dehydroepiandrosterone in physiologic doses modulates immune function in postmenopausal women
Casson, P. R., Andersen, R. N., Herrod, H. G., Stentz, F. B., Straughn, A. B., Abraham, G. E., & Buster, J. E. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90431-h · Cited by 211
CHRISTIANSEN, C., CHRISTENSEN, M. S., LARSEN, N.-E., & TRANSBØL, I. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-6-1124 · Cited by 209
The short-term effects of conjugated estrogen on bone turnover in older women.
Prestwood, K. M., Pilbeam, C. C., Burleson, J., Woodiel, F. N., Delmas, P. D., Deftos, L. J., & Raisz, L. G. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.2.8045949 · Cited by 196
Burger, H., Hailes, J., Menelaus, M., Nelson, J., Hudson, B., & Balazs, N. D. H. (1984) · Maturitas · doi:10.1016/0378-5122(84)90008-2 · Cited by 187
Effect of combined implants of oestradiol and testosterone on libido in postmenopausal women.
Burger, H., Hailes, J., Nelson, J., & Menelaus, M. (1987) · BMJ · doi:10.1136/bmj.294.6577.936 · Cited by 178
Cusan, L., Dupont, A., Gomez, J., Tremblay, R. R., & Labrie, F. (1994) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56518-2 · Cited by 177
Self-citationReduced testosterone and adrenal C19 steroid levels in obese men
Tchernof, A., Després, J.-P., Bélanger, A., Dupont, A., Prud'homme, D., Moorjani, S., Lupien, P. J., & Labrie, F. (1995) · Metabolism · doi:10.1016/0026-0495(95)90060-8 · Cited by 175
Self-citationAndrogenic activity of dehydroepiandrosterone and androstenedione in the rat ventral prostate.
LABRIE, C., BELANGER, A., & LABRIE, F. (1988) · Endocrinology · doi:10.1210/endo-123-3-1412 · Cited by 167
Self-citationModulation of growth, differentiation and carcinogenesis by dehydroepiandrosterone.
Gordon, G. B., Shantz, L. M., & Talalay, P. (1987) · Advances in Enzyme Regulation · doi:10.1016/0065-2571(87)90023-9 · Cited by 159
NATURAL ŒSTROGEN AS AN EFFECTIVE TREATMENT FOR TYPE-II HYPERLIPOPROTEINÆMIA IN POSTMENOPAUSAL WOMEN
Tikkanen, M., Nikkilä, E., & Vartiainen, E. (1978) · The Lancet · doi:10.1016/s0140-6736(78)92216-x · Cited by 149
BARDON, S., VIGKPN, F., CHALBOS, D., & ROCHEFORT, H. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-60-4-692 · Cited by 143
Treatment of hirsutism with the pure antiandrogen flutamide
Cusan, L., Dupont, A., Bélanger, A., Tremblay, R. R., Manhès, G., & Labrie, F. (1990) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(90)70241-9 · Cited by 140
Self-citationAdrenocortical function in old age: response to acute adrenocorticotropin stimulation.
VERMEULEN, A., DESLYPERE, J. P., SCHELFHOUT, W., VERDONCK, L., & RUBENS, R. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-187 · Cited by 135
An easy and reliable method for determination of urinary hydroxyproline
Pødenphant, J., Larsen, N., & Christiansen, C. (1984) · Clinica Chimica Acta · doi:10.1016/0009-8981(84)90110-4 · Cited by 135
Zumoff, B., Levin, J., Rosenfeld, R. S., Markham, M. J., Strain, G. W., & Fukushima, D. K. (1981) · PubMed · Cited by 123
A Review of the Prolonged Use of Estrogens and Androgens in Postmenopausal and Senile Osteoporosis
Henneman, P. H. (1957) · Archives of Internal Medicine · doi:10.1001/archinte.1957.00260110031005 · Cited by 122
Pochi, P. E., & Strauss, J. S. (1969) · Journal of Investigative Dermatology · doi:10.1038/jid.1969.4 · Cited by 120
Weinstein, L., Bewtra, C., & Gallagher, J. C. (1990) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(90)90917-v · Cited by 119
Characterization, Expression, and Immunohistochemical Localization of 5α-Reductase in Human Skin
Luu-The, V., Sugimoto, Y., Puy, L., Labrie, Y., Solache, I. L., Singh, M., & Labrie, F. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371766 · Cited by 118
Self-citationSchriock, E. D., Buffington, C. K., Hubert, G. D., Kurtz, B. R., Kitabchi, A. E., Buster, J. E., & Givens, J. R. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-6-1329 · Cited by 115
Plasma lipids and lipoprotein cholesterol concentrations in people with different diets in Britain.
Thorogood, M., Carter, R., Benfield, L., McPherson, K., & Mann, J. I. (1987) · BMJ · doi:10.1136/bmj.295.6594.351 · Cited by 104
Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice
Coleman, D., Leiter, E. H., & Schwizer, R. W. (1982) · Diabetes · doi:10.2337/diabetes.31.9.830 · Cited by 103
Inhibition of tumor development by dehydroepiandrosterone and related steroids.
Schwartz, A. G., Pashko, L., & Whitcomb, J. M. (1986) · Toxicologic Pathology · doi:10.1177/019262338601400312 · Cited by 101
Studd, J. W. W., Collins, W. P., Chakravarti, S., Newton, R., Oram, D. H., & Parsons, A. (1977) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1977.tb12586.x · Cited by 99
Dumont, M., Luu-The, V., Dupont, É., Pelletier, G., & Labrie, F. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12616131 · Cited by 95
Self-citationSavvas, M., Studd, J. W. W., Fogelman, I., Dooley, M., Montgomery, J., & Murby, B. (1988) · BMJ · doi:10.1136/bmj.297.6644.331 · Cited by 91
The short-term effects of conjugated estrogen on bone turnover in older women
Prestwood, K. M. (1994) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.79.2.366 · Cited by 88
Need, A. G. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390010075007 · Cited by 85
Parker, C. R., Simpson, E. R., Bilheimer, D. W., Leveno, K. J., Carr, B. R., & MacDonald, P. C. (1980) · Science · doi:10.1126/science.6445079 · Cited by 75
The use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women
Colditz, G. A., Hankinson, S. E., Hunter, D. J., Willett, W. C., Manson, J. E., Stampfer, M. J., Hennekens, C. H., ROSNER, B. A., & Speizer, F. E. (1995) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-199511000-00017 · Cited by 70
Li, S., Yan, X., B�langer, A., & Labrie, F. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00665681 · Cited by 70
Self-citationClinical, Biochemical, Radiographic, Epidemiologic, and Economic Features of Osteoporosis
Johnston, C. C., & Epstein, S. (1981) · Orthopedic Clinics of North America · doi:10.1016/s0030-5898(20)31371-7 · Cited by 66
Absorption and Metabolic Effects of Different Types of Estrogens and Progestogens
Løbo, R. A. (1987) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/s0889-8545(21)00577-5 · Cited by 57
Sherwin, B. B., & Gelfand, M. M. (1984) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(84)90746-4 · Cited by 55
Dupont, A., Dupont, P., Cusan, L., Tremblay, M., Rioux, J., Cloutier, D., Mailloux, J. R., Lignieres, B. D., Gutkowska, J., Boucher, H., et al. (1991) · Maturitas · doi:10.1016/0378-5122(91)90238-l · Cited by 50
Self-citationObesity in the dog: role of the adrenal steroid dehydroepiandrosterone (DHEA).
MacEwen, E. G., & Kurzman, I. D. (1991) · The Journal of Nutrition · doi:10.1093/jn/121.suppl_11.s51 · Cited by 49
Stahl, F., Schnorr, D., Pilz, C., & Dörner, G. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0029-1211136 · Cited by 47
Postmenopausal estrogen and androgen replacement and lipoprotein lipid concentrations
Sherwin, B. B., Gelfand, M. M., Schucher, R., & Gabor, J. (1987) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(87)90295-x · Cited by 44
What do we know and what don't we know about tamoxifen in the human uterus
Friedl, A., & Jordan, V. C. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00689674 · Cited by 44
THE DISTRIBUTION OF HYDROXYSTEROID DEHYDROGENASE IN HUMAN SEBACEOUS GLANDS.
Baillie, A. H., THOMSON, J., & MILNE, J. A. (1966) · British Journal of Dermatology · doi:10.1111/j.1365-2133.1966.tb12248.x · Cited by 38
Labrie, F., Simard, J., Luu-The, V., Bèlanger, A., Pelletier, G., Morel, Y., Mébarki, F., Sánchez, R., Durocher, F., Turgeon, C., et al. (1996) · Springer eBooks · doi:10.1007/978-3-662-03230-5_10 · Cited by 34
Self-citationRasmussen, K. R., Arrowood, M. J., & Healey, M. C. (1992) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.36.1.220 · Cited by 33
Need, A. G. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.1.57 · Cited by 29
Direct action of androgen on hot flushes in the human male
DEFAZIO, J., Meldrum, D. R., Winer, J. H., & Judd, H. L. (1984) · Maturitas · doi:10.1016/0378-5122(84)90060-4 · Cited by 23
Chen, C., Bèlanger, A., & Labrie, F. (1996) · Endocrinology · doi:10.1210/endo.137.5.8612511 · Cited by 11
Self-citationEffect of combined implants of oestradiol and testosterone on libido in postmenopausal women
Appleby, L., & Montgomery, J. (1987) · BMJ · doi:10.1136/bmj.294.6584.1417-c · Cited by 8
Chen, C., Li, X., Singh, S. K., Bèlanger, A., & Labrie, F. (1996) · Endocrine Related Cancer · doi:10.1677/erc.0.0030217 · Cited by 6
Self-citationTikkanen, M. J., Nikkilä, E. A., & Vartiainen, E. (1979) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-197902000-00021 · Cited by 3
Weinstein, L., Bewtra, C., & Gallagher, J. C. (1991) · International Journal of Gynecology & Obstetrics · doi:10.1016/0020-7292(91)90651-k · Cited by 2
Flagged first, then by citations
Cited by
Sorted by citations
Knop, E., Knop, N., Millar, T., Obata, H., & Sullivan, D. A. (2011) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.10-6997c · Cited by 1,093
Maninger, N., Wolkowitz, O. M., Reus, V. I., Epel, E. S., & Mellon, S. H. (2009) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2008.11.002 · Cited by 769
Dehydroepiandrosterone Replacement in Women with Adrenal Insufficiency
Arlt, W., Callies, F., van Vlijmen, J. C., Koehler, I., Reincke, M., Bidlingmaier, M., Huebler, D., Oettel, M., Ernst, M., Schulte, H. M., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909303411401 · Cited by 644
DHEA in elderly women and DHEA or testosterone in elderly men.
Nair, K. S., Rizza, R. A., O'Brien, P., Dhatariya, K., Short, K. R., Nehra, A., Vittone, J. L., Klee, G. G., Basu, A., Basu, R., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054629 · Cited by 566
Labrie, F., Luu-The, V., Labrie, C., Bélanger, A., Simard, J., Lin, S.-X., & Pelletier, G. (2003) · Endocrine Reviews · doi:10.1210/er.2001-0031 · Cited by 544
Self-citation
Metadata
- Authors
- Labrie, F., Diamond, P., Cusan, L., Gomez, J.-L., Bélanger, A., & Candas, B.
- Affiliations
- Centre hospitalier de l'Université Laval (CA)
- Corresponding author
- Labrie, Fernand
- ORCID
- Candas, Bernard
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 1997-10
- Volume
- 82
- Issue
- 10
- Pages
- 3498-3505
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1970025509
- Cited by
- 292
- References
- 71
- Citations by year
- 2026: 2 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 2 · 2019: 3 · 2018: 3 · 2017: 6 · 2016: 5 · 2015: 7 · 2014: 5 · 2013: 5 · 2012: 10
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Keywords
- dehydroepiandrosterone, DHEA replacement therapy, postmenopausal women, bone mineral density, endometrial atrophy, osteocalcin, bone-specific alkaline phosphatase, urinary hydroxyproline, osteoporosis prevention, androgenic effects, estrogenic effects
- MeSH terms
- Aged, Atrophy, Bone and Bones, Bone Resorption, Dehydroepiandrosterone, Endometrium, Female, Humans, Middle Aged, Osteogenesis, Sebum, Sex Hormone-Binding Globulin, Vagina, Biomarkers, Bone Density, Bone Remodeling, Postmenopause
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
